Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK

Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK

Metformin is a first-line drug for the management of type 2 diabetes. Recent studies suggested cardioprotective effects of metformin against ischemia/reperfusion injury. However, it remains elusive whether metformin provides direct protection against hypoxia/reoxygenation (H/R) injury in cardiomyocy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingyan Hu, Ping Ye, Hua Liao, Manhua Chen, Feiyan Yang
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2016/2961954
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low doses of ozone alleviate cardiomyocyte ferroptosis induced by hypoxia–reoxygenation injury via the AMPK–mTOR pathway
by: Yu Ding, et al.
Published: (2025-07-01)

Adiponectin Protects Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Suppressing Autophagy
by: Jia Guo, et al.
Published: (2022-01-01)

Protective mechanism of polysaccharides from Phellinus linteus on H9c2 cardiomyocyte injury induced by hypoxia/reoxygenation
by: Xiaoyu Ren, et al.
Published: (2025-07-01)

Shock Wave Therapy Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Ferroptosis
by: Jiannan Wang, et al.
Published: (2024-01-01)

Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKCβ2 Activation and Improving Mitochondrial Quality
by: Yuan Zhang, et al.
Published: (2018-01-01)

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
by: Martta Häkli, et al.
Published: (2022-01-01)

Hypoxia-Reoxygenation Induced Cardiac Mitochondrial Dysfunction
by: Gül Şimşek, et al.
Published: (2018-12-01)

RBM15 promotes hypoxia/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4
by: Yi Cheng, et al.
Published: (2025-07-01)

circRNA-79530 regulates Twist-mediated mitochondrial damage via sponging miR-214 affecting hypoxia/reoxygenation-induced injury in H9c2 cardiomyocytes
by: Ziyang Yu, et al.
Published: (2025-08-01)

AMP-Activated Protein Kinase Activation during Cardioplegia-Induced Hypoxia/Reoxygenation Injury Attenuates Cardiomyocytic Apoptosis via Reduction of Endoplasmic Reticulum Stress
by: Chi-Hsiao Yeh, et al.
Published: (2010-01-01)

Myosin 1b Participated in the Modulation of Hypoxia/Reoxygenation-Caused H9c2 Cell Apoptosis and Autophagy
by: Jing Xu, et al.
Published: (2022-01-01)

Involvement of Nuclear Receptors PPAR-α, PPAR-γ, and the Transcription Factor Nrf2 in Cellular Protection Against Oxidative Stress Regulated by H<sub>2</sub>S and Induced by Hypoxia–Reoxygenation and High Glucose in Primary Cardiomyocyte Cultures
by: Luz Ibarra-Lara, et al.
Published: (2025-04-01)

Acacetin Protects Myocardial Cells against Hypoxia-Reoxygenation Injury through Activation of Autophagy
by: Chong Liu, et al.
Published: (2021-01-01)

Tea Polysaccharide (TPS) Reduces Astrocytes Apoptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation by Regulating the miR-375/SRXN1 Axis
by: Ying Jiang, et al.
Published: (2020-01-01)

The impact of asporin (ASPN) on cardiac myocytes (CM) during in-vitro hypoxia-reoxygenation (H/R) induced apoptosis
by: Deepika Rai, et al.
Published: (2025-06-01)

Neuroprotective properties of the C-Jun N-terminal kinase (JNK) inhibitor in hypoxic hypoxia
by: G. N. Zyuz’kov, et al.
Published: (2019-08-01)

Correction: Wang et al. Anti-Metabolic Syndrome Effects of Fucoidan from <i>Fucus vesiculosus</i> via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling. <i>Molecules</i> 2019, <i>24</i>, 3319
by: Xueliang Wang, et al.
Published: (2025-06-01)

Exenatide Activates the APPL1-AMPK-PPARα Axis to Prevent Diabetic Cardiomyocyte Apoptosis
by: Lei XiaoTian, et al.
Published: (2016-01-01)

Exposure to high altitude leads to disturbances in host metabolic homeostasis: study of the effects of hypoxia-reoxygenation and the associations between the microbiome and metabolome
by: Qin Zhao, et al.
Published: (2025-05-01)

Metformin and berberine synergistically improve NAFLD via the AMPK–SREBP1–FASN signaling pathway
by: Na Li, et al.
Published: (2025-08-01)

The distinct effects of metformin and imeglimin on high glucose-induced alterations in metabolic function and reactive oxygen species production in mouse Schwann cells are modulated by pemafibrate and/or fatty acid-binding proteins.
by: Hiroshi Ohguro, et al.
Published: (2025-08-01)

The Effects of Targeted Temperature Management on Oxygen-Glucose Deprivation/Reperfusion-Induced Injury and DAMP Release in Murine Primary Cardiomyocytes
by: Giang Tong, et al.
Published: (2020-01-01)

Ethanolic and water rhizome extracts of Ligusticum chuanxiong Hort alleviate hypoxia/reoxygenation-injured H9c2 cardiomyoblasts through up-regulated ERK1/2 and Bcl-2 expression
by: Orapin Gerdprasert, et al.
Published: (2024-06-01)

Effects of Hypoxia (Oxygen Glucose Deprivation) on Endothelial Progenitor Cell Function and Shh Signaling Pathway in Rats
by: Jianhua Wang, et al.
Published: (2025-07-01)

Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies
by: Kiera D. Dwyer, et al.
Published: (2025-02-01)

Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways
by: Yating Xu, et al.
Published: (2025-02-01)

Cardiomyocyte OTUD1 drives diabetic cardiomyopathy via directly deubiquitinating AMPKα2 and inducing mitochondrial dysfunction
by: Xue Han, et al.
Published: (2025-07-01)

ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured Cardiomyocytes
by: Guodong Pan, et al.
Published: (2016-01-01)

Reactive Oxidative Species in Carotid Body Chemoreception: Their Role in Oxygen Sensing and Cardiorespiratory Alterations Induced by Chronic Intermittent Hypoxia
by: Rodrigo Iturriaga, et al.
Published: (2025-06-01)

MicroRNA-133b Alleviates Hypoxia Injury by Direct Targeting on NOD-Like Receptor Protein 3 in Rat H9c2 Cardiomyocyte
by: Yongmei Zhou, et al.
Published: (2019-01-01)

Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunction
by: Faten Habrat Zoabi, et al.
Published: (2025-01-01)

The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
by: Derek T Hall, et al.
Published: (2018-05-01)

Suppression of NOX2-Derived Reactive Oxygen Species (ROS) Reduces Epithelial-to-MesEnchymal Transition Through Blocking SiO<sub>2</sub>-Regulated JNK Activation
by: Guanhan Xiang, et al.
Published: (2025-04-01)

Single-atom Pt-doped ceria nanozymes mitigate myocardial ischemia reperfusion injury via cardiomyocyte-targeted uptake and suppression of reactive oxygen species
by: Aoyang Pu, et al.
Published: (2025-11-01)

Metformin-regulated glucose flux from the circulation to the intestinal lumen
by: Kazuhiko Sakaguchi, et al.
Published: (2025-03-01)

Propolis, a Constituent of Honey, Inhibits the Development of Sugar Cataracts and High-Glucose-Induced Reactive Oxygen Species in Rat Lenses
by: Teppei Shibata, et al.
Published: (2016-01-01)

Oxygen-Loaded Nanodroplets Effectively Abrogate Hypoxia Dysregulating Effects on Secretion of MMP-9 and TIMP-1 by Human Monocytes
by: Giulia Rossana Gulino, et al.
Published: (2015-01-01)

GAS5 silencing attenuates hypoxia‐induced cardiomyocytes injury by targeting miR‐21/PTEN
by: Qianli Wang, et al.
Published: (2023-07-01)

Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells
by: Lu Sun, et al.
Published: (2025-02-01)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
by: Mei Xiang, et al.
Published: (2018-09-01)